Language usage and social maturity as related to suicide notes.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 5902192)

Published in J Soc Psychol on February 01, 1966

Authors

J Tuckman, R Ziegler

Articles by these authors

(truncated to the top 100)

Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet (2001) 3.62

Reduced pulmonary function in patients with spinal osteoporotic fractures. Osteoporos Int (1998) 2.45

Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest (1994) 2.30

Uptake and transport of herpes simplex virus in neurites of rat dorsal root ganglia cells in culture. J Gen Virol (1984) 2.22

Effect of clodronate treatment on bone scintigraphy in metastatic breast cancer. J Nucl Med (1993) 2.20

Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care (1997) 2.18

Role of NFkappaB in the mortality of sepsis. J Clin Invest (1997) 2.18

Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet (2000) 1.98

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res (1998) 1.77

Circaannual rhythms and interactions of vitamin D metabolites, parathyroid hormone, and biochemical markers of skeletal homeostasis: a prospective study. J Bone Miner Res (2000) 1.66

Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol. Br J Clin Pharmacol (1976) 1.53

Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus. Exp Clin Endocrinol Diabetes (1997) 1.48

Anthroposophic therapies in chronic disease: the Anthroposophic Medicine Outcomes Study (AMOS). Eur J Med Res (2004) 1.45

Comparison of total and bone-specific alkaline phosphatase in patients with nonskeletal disorder or metabolic bone diseases. Clin Chem (1996) 1.45

Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes (1997) 1.42

Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Clin Endocrinol Metab (2001) 1.42

DNA uptake during genetic transformation and the growing zone of the cell envelope. Proc Natl Acad Sci U S A (1971) 1.41

Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin. Exp Clin Endocrinol Diabetes (1998) 1.40

[Thoracic pain in a power athlete]. Internist (Berl) (1997) 1.39

Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia (1999) 1.38

Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Circulation (1997) 1.38

[Androgens and bone metabolism. Significance in osteoporosis in man and woman]. Dtsch Med Wochenschr (1992) 1.38

Binding of the competence factor to receptors in the spheroplast membrane of pneumococci. Biochem Biophys Res Commun (1970) 1.37

The role of oxidative stress and NF-kappaB activation in late diabetic complications. Biofactors (1999) 1.33

Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab (1997) 1.32

A study of complaints and their relation to vertebral destruction in patients with osteoporosis. Bone Miner (1990) 1.30

Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. Diabetes Res Clin Pract (2001) 1.28

Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone. J Clin Invest (1995) 1.27

Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption. Clin Endocrinol (Oxf) (1996) 1.23

On the phylogenetic position of the pre-Neandertal specimen from Reilingen, Germany. J Hum Evol (1998) 1.21

Diabetes mellitus a risk for osteoporosis? Exp Clin Endocrinol Diabetes (2001) 1.20

Prognostic value of codon 918 (ATG-->ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. Int J Cancer (2001) 1.20

Seasonal variation of biochemical indexes of bone turnover: results of a population-based study. J Clin Endocrinol Metab (1998) 1.17

Increase of patients co-colonised or co-infected with methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium or extended-spectrum β-lactamase-producing Enterobacteriaceae. Infection (2011) 1.17

Release of thrombomodulin from endothelial cells by concerted action of TNF-alpha and neutrophils: in vivo and in vitro studies. Immunology (1996) 1.17

Life-table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type I diabetes. Diabetes (1989) 1.16

Quality of life and vertebral osteoporosis. Osteoporos Int (1992) 1.15

Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study. Altern Ther Health Med (2001) 1.15

Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes. Diabetes Care (1998) 1.15

Clinical grading of spinal osteoporosis: quality of life components and spinal deformity in women with chronic low back pain and women with vertebral osteoporosis. J Bone Miner Res (1997) 1.13

Chemotactic response of osteoblastlike cells to transforming growth factor beta. J Bone Miner Res (1990) 1.13

Stimulation of bone matrix apposition in vitro by local growth factors: a comparison between insulin-like growth factor I, platelet-derived growth factor, and transforming growth factor beta. Endocrinology (1990) 1.12

Anthroposophic vs. conventional therapy for chronic low back pain: a prospective comparative study. Eur J Med Res (2007) 1.09

Characterization of insulin autoantibodies in relatives of patients with type I diabetes. Diabetes (1993) 1.09

Pharmacological basis for antihypertensive effects of intravenous labetalol. Br Heart J (1977) 1.08

[Experiences with nifedipine in the treatment of acute hypertension in childhood]. Monatsschr Kinderheilkd (1985) 1.07

Changes in bone turnover induced by aerobic and anaerobic exercise in young males. J Bone Miner Res (1998) 1.06

Effect of different degrees of tilt on cardiac output, heart rate, and blood pressure in normal man. Br Heart J (1966) 1.05

The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-kappa B. Thromb Haemost (1997) 1.05

sn-1,2-Diacylglycerols and phorbol diesters stimulate thromboxane synthesis by de novo synthesis of prostaglandin H synthase in human promyelocytic leukemia cells. J Clin Invest (1987) 1.04

Comprehensive analysis of hormone and genetic variation in 36 genes related to steroid hormone metabolism in pre- and postmenopausal women from the breast and prostate cancer cohort consortium (BPC3). J Clin Endocrinol Metab (2010) 1.00

Binding of acetylated low density lipoprotein and maleylated bovine serum albumin to the rat liver: one or two receptors? EMBO J (1987) 1.00

Pharmacokinetics and metabolism of calcium-blocking agents nifedipine, nitrendipine, and nimodipine. Am J Nephrol (1986) 1.00

Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices. J Bone Miner Res (1999) 0.99

Diagnosis and management of pheochromocytomas in patients with multiple endocrine neoplasia type 2-relevance of specific mutations in the RET proto-oncogene. Eur J Endocrinol (1996) 0.99

Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in vitro. J Bone Miner Res (1997) 0.99

Lower serum 25-hydroxyvitamin D is associated with increased bone resorption markers and lower bone density at the proximal femur in normal females: a population-based study. Exp Clin Endocrinol Diabetes (1996) 0.99

Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis). Exp Clin Endocrinol (1994) 0.98

Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care (1998) 0.98

Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas. Surgery (2001) 0.97

Implication of specific DQB1 alleles in genetic susceptibility and resistance by identification of IDDM siblings with novel HLA-DQB1 allele and unusual DR2 and DR1 haplotypes. Diabetes (1991) 0.97

Vascular origin of Kaposi's sarcoma. Expression of leukocyte adhesion molecule-1, thrombomodulin, and tissue factor. Am J Pathol (1994) 0.97

Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement. J Clin Endocrinol Metab (1995) 0.96

Combination chemotherapy of advanced medullary and differentiated thyroid cancer. Phase II study. J Cancer Res Clin Oncol (1990) 0.96

Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy. J Clin Endocrinol Metab (1993) 0.95

Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: high sensitivity of selective venous catheterization. Thyroid (1992) 0.95

The hypercalcaemic syndrome in rats bearing the Walker carcinosarcoma 256. Acta Endocrinol (Copenh) (1975) 0.95

Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity. J Clin Invest (1998) 0.95

Association of transforming growth factor-beta1 (TGFbeta1) T29 --> C gene polymorphism with bone mineral density (BMD), changes in BMD, and serum concentrations of TGF-beta1 in a population-based sample of postmenopausal german women. Calcif Tissue Int (2001) 0.95

17 beta-estradiol inhibits LDL oxidation and cholesteryl ester formation in cultured macrophages. Free Radic Res Commun (1990) 0.94

A newly developed spine deformity index (SDI) to quantitate vertebral crush fractures in patients with osteoporosis. Bone Miner (1988) 0.93

Persistent inhibition of gastric secretion by an intravenous 12-hour infusion of calcitonin in normals, peptic ulcer and high risk patients. Digestion (1974) 0.92

Concentration of insulin-like growth factor (IGF)-I and -II in iliac crest bone matrix from pre- and postmenopausal women: relationship to age, menopause, bone turnover, bone volume, and circulating IGFs. J Clin Endocrinol Metab (1998) 0.92

Apolipoprotein E phenotypes and hyperlipidemia in patients under maintenance hemodialysis. Hum Genet (1992) 0.92

Endothelin-1 is a potent regulator of human bone cell metabolism in vitro. Calcif Tissue Int (1997) 0.92

Skeletal site-dependent expression of the androgen receptor in human osteoblastic cell populations. Calcif Tissue Int (1997) 0.91

Molecular cloning of genes differentially regulated by TNF-alpha in bovine aortic endothelial cells, fibroblasts and smooth muscle cells. Cardiovasc Res (1998) 0.91

Concentration of transforming growth factor beta in human bone tissue: relationship to age, menopause, bone turnover, and bone volume. J Bone Miner Res (1998) 0.90

Cell specific effects of glucocorticoid treatment on the NF-kappaBp65/IkappaBalpha system in patients with Crohn's disease. Gut (1999) 0.90

Size of family and behavioral problems in children. J Genet Psychol (1967) 0.90

Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women. J Clin Endocrinol Metab (1996) 0.90

[Paget's disease of bone: ultrastructure and cytogenesis of osteoclasts (author's transl)]. Virchows Arch A Pathol Anat Histol (1977) 0.90

Inhibition of gastric secretion in man by oral administration of calcitonin. Digestion (1974) 0.90

A simple assay for galactokinase using DEAE-cellulose column chromatography. Clin Chim Acta (1977) 0.89

Acute hypercalcemia due to Walker carcinosarcoma 256 in the rat. Horm Metab Res (1970) 0.89

Localisation of protein Z in vascular lesions of patients with atherosclerosis. Vasa (1998) 0.89

Decreased serum levels of insulin-like growth factors and IGF binding protein 3 in osteoporosis. J Intern Med (1993) 0.89

Human bone cell phenotypes differ depending on their skeletal site of origin. J Clin Endocrinol Metab (1995) 0.89

Transforming growth factor beta (TGF-beta) levels in the conditioned media of human bone cells: relationship to donor age, bone volume, and concentration of TGF-beta in human bone matrix in vivo. Bone (1999) 0.89

Clinical features of type III hyperlipoproteinemia: analysis of 64 patients. Clin Investig (1993) 0.88

A scale for assessing suicide risk of attempted suicides. J Clin Psychol (1968) 0.88

The influences of acute hyper- and hypocalcemia and of calcitonin on exocrine pancreatic function in man. Res Exp Med (Berl) (1973) 0.88

Bone disease after liver transplantation. Transplant Proc (1992) 0.88

alpha-Lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria. Free Radic Biol Med (1999) 0.88

Smoking influences the atherogenic potential of low-density lipoprotein. Clin Investig (1992) 0.88

Intravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor-induced tissue factor expression and fibrin deposition in mouse meth-A sarcoma. J Clin Invest (1996) 0.88

Increased incidence of euthyroid and hyperthyroid goiters independently of thyrotropin in patients with acromegaly. Horm Metab Res (1991) 0.87

Somatostatin receptor imaging in persistent medullary thyroid carcinoma. Clin Endocrinol (Oxf) (1995) 0.87

Binding characteristics of reduced hepatic receptors for acetylated low-density lipoprotein and maleylated bovine serum albumin. Biochem J (1990) 0.87

Apolipophorin III is dramatically up-regulated during the programmed death of insect skeletal muscle and neurons. J Neurobiol (1995) 0.87